ATTD: Advanced Technologies and Treatments for Diabetes
ATTD: Advanced Technologies and Treatments for Diabetes
Podcast Description
ATTD is the ultimate forum to discover the latest diabetes research, devices, therapies and developments worldwide. This show, “ATTD Conference Catch-up”, will use AI podcasting to extract key insights from expert presentations and research discussions, transforming them into short, easy-to-digest episodes for busy healthcare professionals like you. So if you’re a diabetes specialist, researcher, or industry leader, this podcast is made for you.
Hit subscribe, and let’s explore the future of diabetes treatment, one breakthrough at a time.
Podcast Insights
Content Themes
The podcast focuses on the latest advancements in diabetes research and treatment, covering topics such as gene therapy, continuous glucose monitoring, and innovative technology applications in diabetes management, with specific episodes discussing beta cell therapies and the role of AI in diabetes care.
ATTD is the ultimate forum for the latest in diabetes research, technology, and clinical innovation. This podcast channel offers two types of content designed for busy healthcare professionals:
* ATTD Conference Catch-up: Short, AI-generated episodes with key insights from expert presentations and research discussions at the ATTD Conference.
* Curated Series: In-depth, human-led conversations on topics like Long-Acting Insulin Uncovered, featuring expert interviews and real-world stories, supported by Eli Lilly.
Whether you’re a specialist, researcher, or industry leader, hit subscribe.
In the first episode of our new series CGM in Focus, supported by Dexcom, host Dr David Kerr takes a closer look at AI-Driven CGM, its impact on the latest technology in continuous glucose monitoring, and what it means in practice for clinicians and patients alike.
To discuss this exciting topic, Dr Kerr is joined by Consultant Physician in Metabolic Medicine, Dr Shivani Misra.
They cover:
The Role of AI in Continuous Glucose Monitoring
Challenges and Potential of AI in Diabetes Management
AI and CGM for Young People with Diabetes
Potential for AI to instigate behaviour change
Dr Shivani Misra is a Consultant Physician in Metabolic Medicine, a Wellcome Trust-funded investigator, and Head of Metabolic Medicine at Imperial College London. Dr Misra specialises in early-onset type 2 diabetes, atypical and non-classical diabetes phenotypes, and congenital hyperinsulinism.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.